Young-Jin Jung
Direktor/Vorstandsmitglied bei POLUS BIOPHARM INC.
Vermögen: 149 953 $ am 30.04.2024
Profil
Young-Jin Jung is an Independent Director at POLUS BioPharm, Inc. since 2016.
Prior to this, he was an Independent Director at SillaJen, Inc. He holds a graduate degree from Seoul National University, a doctorate from Korea University, and a graduate degree from Northwestern University School of Law.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SMEDI CO., LTD.
0,28% | 12.06.2023 | 398 558 ( 0,28% ) | 149 953 $ | 30.04.2024 |
Aktive Positionen von Young-Jin Jung
Unternehmen | Position | Beginn |
---|---|---|
POLUS BIOPHARM INC. | Direktor/Vorstandsmitglied | 14.07.2016 |
Ehemalige bekannte Positionen von Young-Jin Jung
Unternehmen | Position | Ende |
---|---|---|
SILLAJEN, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Young-Jin Jung
Seoul National University | Graduate Degree |
Northwestern University School of Law | Graduate Degree |
Korea University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SILLAJEN, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
POLUS BioPharm, Inc.
POLUS BioPharm, Inc. BiotechnologyHealth Technology POLUS BioPharm, Inc. engages in the manufacture and sale of electrical measuring, testing and analyzing instruments. Its main products include test and measuring instruments and telecommunication system. The test and measuring instruments consist of analyzer, analog oscilloscope, digital storage oscilloscope, generator, meter, counter, and power supply. The telecommunication system includes base station solutions, coverage solutions, RF power amplifiers and RF conditioning products. Its macsra product provides electricity setting level through surge protector. The company was founded on February 2, 1972 and is headquartered in Incheon, South Korea. | Health Technology |